reestenose tardia associada à fratura de stent cypher reestenosis tardía asociada a fractura de stent cypher late restenosis related to cypher stent fracture
Clicks: 234
ID: 219194
2009
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
234 views
39 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #96 of 230 articles by views in revista cubana de ciencias informáticas
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 230 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Os stents farmacológicos representam um importante avanço na terapêutica da doença aterosclerótica coronariana. Recentemente tem sido descrita a fratura de stents farmacológicos, associada à reestenose e trombose. Relataremos aqui um caso de fratura de um stent farmacológico 18 meses após o seu implante, associada com reestenose.
Los stents farmacológicos representan un importante avance en la terapéutica de la enfermedad aterosclerótica coronaria. Recientemente se ha descrito la fractura de stents farmacológicos, asociada a la reestenosis y trombosis. Relataremos aquí un caso de fractura de un stent farmacológico 18 meses después de su implante, asociada con reestenosis.
Drug-eluting stents represent a significant evolution in the therapy of coronary artery disease. Recently, restenosis and thrombosis related to drug-eluting stent fractures have been described. This work reports a case of fracture of a drug-eluting stent 18 months after implantation, associated with restenosis.
Los stents farmacológicos representan un importante avance en la terapéutica de la enfermedad aterosclerótica coronaria. Recientemente se ha descrito la fractura de stents farmacológicos, asociada a la reestenosis y trombosis. Relataremos aquí un caso de fractura de un stent farmacológico 18 meses después de su implante, asociada con reestenosis.
Drug-eluting stents represent a significant evolution in the therapy of coronary artery disease. Recently, restenosis and thrombosis related to drug-eluting stent fractures have been described. This work reports a case of fracture of a drug-eluting stent 18 months after implantation, associated with restenosis.
| Reference Key |
cadore2009arquivosreestenose
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Michel Pereira Cadore;Henrique Pereira Abelin;Romualdo Bolzani dos Santos;Paulo Ricardo Avancini Caramori |
| Journal | revista cubana de ciencias informáticas |
| Year | 2009 |
| DOI |
10.1590/S0066-782X2009001100021
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.